Aggressive Shorting in BRVE
Recent data from Ortex highlights a massive escalation in bearish positioning for Braveheart Bio (BRVE). Short interest has surged to 648% of the free float, representing a 411 percentage-point increase in just one week.
Market Context
While short interest is at an extreme level, borrow availability currently sits at 95%, suggesting that short sellers are still finding inventory to enter new positions. This high-conviction shorting creates a volatile setup; while the borrow market is not yet constrained, the sheer scale of the short interest relative to the float makes the stock highly sensitive to any positive catalysts that could trigger forced buying or a short squeeze.
Key Takeaways
- Short interest has spiked to 648% of free float.
- Weekly increase of 411 percentage points marks a record jump in recent dataset.
- Borrow availability remains high at 95%, allowing continued entry for bears.
The Bottom Line
BRVE has become a primary target for aggressive short sellers. Investors should watch for any sudden shifts in borrow availability, which, if tightened, could turn this massive short position into a high-risk squeeze candidate.
Signal data sourced from Ortex. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.